BioCatalystWatch
BOLTWorkspace / BOLT / OverviewCompany library
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. (BOLT)

Website

Price
Market cap
Next catalystClinical data: H2 2027Program 2 — planned first-in-human studies · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

BDC-4182

Claudin 18.2 (CLDN18.2) × TLR7/8

PreINDP1P2P3FilingApproved
Upcoming / outlook

PRA-216

IL-4Rα × TSLP

PreINDP1P2P3FilingApproved
Upcoming / outlook

PRA-216

IL-4Rα × TSLP

PreINDP1P2P3FilingApproved
Upcoming / outlook

PRA-216

IL-4Rα × TSLP

PreINDP1P2P3FilingApproved
Upcoming / outlook

PRA-216

IL-4Rα × TSLP

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Program 2

IL-31 × undisclosed specificity

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Partner / License out

History / paused

HER2

PreINDP1P2P3FilingApproved

HER2

PreINDP1P2P3FilingApproved
PRA-216

IL-4Rα × TSLP

PreINDP1P2P3FilingApproved

PD-L1 (CD274)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BOLT PR & News

PR & News

BOLT SEC archive